Staffordshire Bull Terriers in the UK: their disorder predispositions and protections by Pegram, C et al.
RESEARCH Open Access
Staffordshire Bull Terriers in the UK:
their disorder predispositions and
protections
Camilla Pegram1* , Katie Wonham2, Dave C. Brodbelt1, David B. Church3 and Dan G. O’Neill1
Abstract
Background: The Staffordshire Bull Terrier is a popular dog breed in the UK but there is limited reliable evidence
on disorder predispositions and protections within the breed. Using anonymised veterinary clinical data from the
VetCompass™ Programme, this study aimed to identify common disorders with predisposition and protection in the
Staffordshire Bull Terrier. The study hypothesised that Staffordshire Bull Terriers would have higher odds of
aggression compared with non-Staffordshire Bull Terriers.
Results: The clinical records of a random sample of dogs of all types were reviewed to extract the most definitive
diagnoses for all disorders existing during 2016. A combined list from the 30 most common disorders in
Staffordshire Bull Terriers and the 30 most common disorders in non-Staffordshire Bull Terriers was generated.
Multivariable logistic regression was used to report the odds of each of these disorders in 1304 (5.8%) Staffordshire
Bull Terriers compared with 21,029 (94.2%) non-Staffordshire Bull Terriers. After accounting for confounding,
Staffordshire Bull Terriers had significantly increased odds of 4/36 (11.1%) disorders compared to non-Staffordshire
Bull Terriers with highest odds for seizure disorder (OR 2.06; 95% CI 1.24 to 3.40; p = 0.005). Conversely, Staffordshire
Bull Terriers had reduced odds of 5/36 (13.9%) disorders, with lowest odds for patellar luxation (OR 0.15; 95% CI 0.04
to 0.61; p = 0.008). There was no significant difference in the odds of aggression between Staffordshire Bull Terriers
compared with non-Staffordshire Bull Terriers (OR 1.09; 95% CI 0.75 to 1.58; p = 0.644).
Conclusions: This study provides a reliable evidence base of breed-specific disorder predispositions and protections
that can be used by breeders to optimise breeding decisions. The findings can assist prospective owners of
Staffordshire Bull Terriers to make informed decisions when acquiring a dog. From the relative number of
predispositions to protections identified, there is no evidence that Staffordshire Bull Terriers have higher overall
health problems than non-Staffordshire Bull Terriers.
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Plain English summary
The Staffordshire Bull Terrier (SBT) is currently a popu-
lar dog breed in the UK. However there is limited infor-
mation on disorders to which SBTs are predisposed and
disorders to which the breed is protected. Using veterin-
ary clinical data from the VetCompass™ Programme at
the Royal Veterinary College, this study aimed to identify
disorders with predisposition and protection in the SBT.
The study hypothesised that SBTs would have higher
risk of aggression compared with non-SBTs.
The study included 1304 (5.8%) SBTs and 21,029
(94.2%) non-SBTs. SBTs were predisposed to 4/36
(11.1%) specific disorders compared to non-SBTs with
the breed at over twice the risk of seizure disorder com-
pared with dogs that were not SBTs. Conversely, SBTs
were identified as protected to 5/36 (13.9%) specific dis-
orders. Slipping kneecap (patellar luxation) had the low-
est risk with SBTs having almost seven times less risk
than dogs that were not SBTs. SBTs did not show in-
creased risk of aggression compared with non-SBTs.
This study provides a reliable evidence base of breed-
specific disorder predispositions and protections that
can be used by breeders to optimise breeding decisions.
The results also assist prospective SBT owners to make
an informed decision when acquiring a dog. From the
relative number of predispositions to protections identi-
fied, there is no evidence that SBTs have higher overall
health problems than non-SBTs.
Background
The Staffordshire Bull Terrier (SBT) was first recognised as
a breed by the UK Kennel Club (KC) in 1935 [1]. Devel-
oped as a fighting dog in the UK in the nineteenth century,
the breed is thought to have originated in Birmingham and
Staffordshire by cross-breeding the bulldog and English ter-
rier [1]. The SBT is currently a popular breed in the UK, re-
cently identified as the second most common purebred in
the wider general dog population under primary veterinary
care [2]. Conversely, SBTs are less popular among the regis-
tered pedigree subset of UK dogs, being placed as the 12th
most commonly registered breed by the KC in 2018–2019
[3], with registrations declining by 52.4% from 8663 in 2010
to 4124 in 2016 [4]. However, registrations have since
remained relatively stable [4].
A recent textbook that reviewed the general literature
for disease predispositions across all dog breeds reported
SBTs as predisposed to 20 disorders, including aggres-
sion, atopic dermatitis, demodicosis, elbow dysplasia,
mammary neoplasia and corneal ulceration. However
these studies varied widely in study design, date, geo-
graphical location and comparator groups [5]. A genetic
basis for aggression in SBTs has been described [6] and
a survey of UK veterinarians classified SBTs with high
aggression while SBTs were over-represented as the
aggressor in dog-dog conflict in Germany [5–7]. SBTs
are a common breed in rehoming centres and, due to
their perceived behavioural issues, are reportedly difficult
to rehome [8]. However, despite their reputation, given
responsible ownership and an enriched environment,
SBTs can make a suitable family pet [9]. Indeed, the UK
KC Breed Standard describes SBTs as “highly intelligent
and affectionate especially with children” [1].
The KC reports three inheritable conditions to which
SBT’s are predisposed: hereditary cataracts (HC-HSF4), L-
2-hydroxyglutaric aciduria (L-2HGA) and persistent hyper-
plastic primary vitreous (PHPV) [1]. Therefore, eye testing
and DNA tests for HC-HSF4 and L-2HGA for SBT breed-
ing parents are mandatory for KC assured breeders and eye
screening for PHPV for all puppies is recommended [1].
However, despite the importance accorded to these condi-
tions by these requirements, prevalence estimates for these
conditions within the general UK population of SBTs are
limited and the studies that do exist have reported these
conditions as rare [10–13].
In order to better understand the relevance of individ-
ual disorders to the health profile of a breed, both abso-
lute risk (prevalence) as well as relative risk information
(predisposition and protection) need to be considered.
Relatively small decreases in a highly prevalent disorder
may confer substantial health advantage whereas even
large reductions in a high predisposition for a rare dis-
order may offer minimal overall health impact for a
breed [14]. A previous VetCompass™ study reported that
certain purebreeds may have a higher prevalence of
some common disorders compared with crossbred dogs.
However, of the common, specific disorders, only obesity
had a higher prevalence in SBTs compared to crossbred
dogs (6.0% in SBTs vs. 3.9% in crossbred dogs). The
prevalence estimates for other specific disorders were
lower for SBTs compared to crossbreds, including: peri-
odontal disease (2.4% vs 9.2%), degenerative joint disease
(5.4% vs 7.5%), and lipoma (2.1% vs 3.8%), suggesting a
relatively good overall health status for the breed [2].
Whilst SBTs are often considered relatively healthy
[15], and with median longevity reported as 10.7–12.8
years [16, 17], evidence on disorder protection within
SBTs, or indeed any breed, is limited. To date, breed
protections to disorders have not been commonly re-
ported within canine populations. However, deeper un-
derstanding of breed protections offers the potential to
teach us as much about how to breed healthier dogs by
breeding towards low disorder risk rather than just try-
ing to breed away from high disorder risk as is the
current preference in many dog breeding strategies [18].
Using anonymised veterinary clinical data from the
VetCompass Programme [19], this study aimed to com-
pare the odds of common disorders between SBTs and
all remaining dogs under primary veterinary care in the
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UK during 2016 after accounting for major confounding
variables and therefore to identify disorders with predis-
position and protection in the SBT. The study hypothe-
sized that SBTs have higher odds of aggression
compared with non-SBTs. These results could assist
breeders, veterinary practitioners and owners with an
evidence base on the wider general population of dogs
to predict, prevent and manage key health and welfare
opportunities for SBTs.
Methods
The study population included all available dogs under
primary veterinary care at clinics participating in the
VetCompass Programme during 2016. Dogs under veter-
inary care were defined as those with either a) at least
one electronic patient record (EPR) (VeNom diagnosis
term, free-text clinical note, treatment or bodyweight)
recorded during 2016 or b) at least one EPR recorded
during both 2015 and 2017. VetCompass collates de-
identified EPR data from primary-care veterinary prac-
tices in the UK for epidemiological research [20]. Data
fields available to VetCompass researchers include a
unique animal identifier along with species, breed, date
of birth, sex, neuter status, insurance status and body-
weight, and also clinical information from free-form text
clinical notes, summary diagnosis terms [21] and treat-
ment with relevant dates.
A cohort study design was used to estimate the one-year
(2016) period prevalence of the most commonly diag-
nosed disorders in a random sample of SBTs and a ran-
dom sample of all other dogs [22]. Sample size
calculations for increased odds of aggression in SBTs in
Epi info (CDC) estimated that approximately 681 SBTs
and 13,610 non-SBTs would be needed to detect an odds
ratio of ≥1.75, based on an estimated 5% of SBTs being re-
corded with aggression during the study period, with 80%
power and 95% confidence assuming an approximate 20:1
ratio of non-SBTs to SBTs in the study population [2, 23].
Ethics approval was obtained from the RVC Ethics and
Welfare Committee (reference number SR2018–1652).
Breed information entered by the participating prac-
tices was cleaned and mapped to a VetCompass breed
list derived and extended from the VeNom Coding
breed list [21]. Dogs recorded as SBT were categorised
as SBT and dogs recorded with any other breed term
were categorised as non-SBT. Neuter status was defined
by the final available EPR neuter value and was com-
bined with sex: female entire, female neutered, male en-
tire and male neutered. Adult bodyweight was defined as
the mean of all bodyweight (kg) values recorded for each
dog after reaching 18 months old. Mean adult body-
weight was reported overall and broken down by sex for
all breeds with adult bodyweight available for at least
100 dogs. Bodyweight was further categorized as “at or
above the breed/sex mean”, “below the breed/sex mean”
and “no recorded bodyweight”. Age (years) at the final
study date (December 31, 2016) was categorised: ≤ 3.0,
3.0 to < 6.0, 6.0 to < 9.0, 9.0 to < 12.0 and ≥ 12.0. Veterin-
ary group attended was categorised as 1–5, based on the
5 practice groups involved in the study. The practice
groups included in the current study were distributed
throughout the UK and were assigned a code during analysis
to ensure anonymity. Insurance status was categorised as in-
sured or not insured as recorded by the final available EPR.
The list of unique animal identification numbers for
all dogs under veterinary care in 2016 was randomly or-
dered and the clinical records of a randomly selected
subset of animals were reviewed manually in detail to
extract the most definitive diagnoses recorded for all dis-
orders that existed during 2016 [2]. Elective (e.g. neuter-
ing) or prophylactic (e.g. vaccination) clinical events
were not included. No distinction was made between
pre-existing and incident disorder presentations. Disor-
ders described within the clinical notes using presenting
sign terms (e.g. ‘vomiting’ or ‘vomiting and diarrhoea’),
but without a formally recorded clinical diagnostic term,
were included using the first sign listed (e.g. vomiting).
Aggression was included as a specific disorder term and
included all dogs where the clinical records showed evi-
dence of aggressive behaviour of any type during 2016.
This definition was applied equally between SBTs and
non-SBTSs. The extracted diagnosis terms were mapped
to a dual hierarchy of diagnostic precision for analysis:
specific-level precision and grouped-level precision as
previously described [2]. Briefly, specific-level precision
terms described the original extracted terms at the max-
imal diagnostic precision recorded within the clinical
notes (e.g. inflammatory bowel disease would remain as
inflammatory bowel disease). Grouped-level precision
terms mapped the original diagnosis terms to a general
level of diagnostic precision (e.g. inflammatory bowel
disease would map to gastro-intestinal).
Following data checking for internal validity and clean-
ing in Excel (Microsoft Office Excel 2013, Microsoft
Corp.), analyses were conducted using SPSS version 24.0
(IBM Corp). The sex-neuter status, age, adult body-
weight and insurance status for SBTs and non-SBTs
under veterinary care during 2016 were described.
One-year period prevalence values were reported separ-
ately for SBTs and non-SBTs to describe the probability of
diagnosis at least once during 2016. The final combined list
of 36 disorders included the 30 most common disorders in
SBTs and the 30 most common disorders in non-SBTs.
Continuous variables were non-normally distributed and so
were summarised using median, interquartile range (IQR)
and range. Mann-Whitney U test, chi-square test and Fish-
er’s exact test were used as appropriate for comparison of
demographic data between cases and non-cases [24, 25].
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Multivariable modelling using binary logistic regression was
used to report the odds of each of these diseases in SBTs
compared with non-SBTs. A separate model was created
for each specific-level and grouped disorder. Information
theory was applied to generate a list of confounding vari-
ables that was consistently included alongside the breed
variable in each model [26, 27]. Breed was an a priori fac-
tor of interest and the models additionally included age
(years), sex-neuter status, at/above or below mean body-
weight, insurance status and vet group. Model fit was
assessed with the Hosmer-Lemeshow Test [28]. Statistical
significance was set at the 5% level. All figures were cre-
ated in R statistical software (R version 3.6.2) using the
“forestplot” package [29].
Results
The analysis included a random sample of 22,333 (2.5%)
dogs from the study population of 905,544 dogs under
veterinary care during 2016 in the UK. Of these, 1304
(5.8%) were SBTs, the second most common purebred
breed. The other most common breeds included 1462
(6.5%) Labrador Retrievers, 1168 (5.2%) Jack Russell Ter-
riers, 793 (3.6%) Shih-tzus, 771 (3.5%) Cocker Spaniels,
along with 5981 (26.8%) crossbreeds. Data completeness
were: breed 100.0%, age 98.8%, sex-neuter status 99.7%,
insurance status 100.0% and bodyweight 66.6%.
Descriptive results were reported on 1304 SBTs and
21,029 non-SBTs (Table 1). The median age of SBTs
(5.65 years, IQR 2.55–8.83, range 0.14–18.95) was older
than for non-SBTs (4.33 years, IQR 1.84–7.98, range
0.01–20.46) (p < 0.001). The median bodyweight of
SBTs (20.20 kg, IQR 17.68–22.86, range 12.47–31.00)
was heavier than for non-SBTs of (12.65 kg, IQR 7.90–
25.40, range 1.41–85.00) (p < 0.001).
Of the SBTs, 831/1304 (63.7%) were diagnosed with ≥1
disorder compared with 13,873/21,029 (66.0%) of the non-
SBTs. After using multivariable methods to account for ef-
fects of age, sex-neuter status, at/above or below mean
bodyweight, insurance status and vet group, the odds of
diagnosis with ≥1 disorder did not significantly differ in
SBTs compared with non-SBTs (odds ratio [OR] 0.90;
95% confidence interval [CI] 0.80 to 1.02; p = 0.102).
At a specific-level of diagnostic precision, after ac-
counting for confounding using multivariable methods,
SBTs had significantly increased odds of 4/36 (11.1%)
specific-level disorders compared to non-SBTs. These
were: seizure disorder (OR 2.06; 95% CI 1.24 to 3.40;
p = 0.005), atopic dermatitis (OR 1.88; 95% CI 1.24 to
2.84; p = 0.003), skin mass (OR 1.80; 95% CI 1.43 to 2.45;
p < 0.001) and stiffness (OR 1.76; 95% CI 1.02 to 3.05;
p = 0.043). Conversely, SBTs had significantly reduced
odds of 5/36 (13.9%) specific-level disorders compared
to non-SBTs. These were: anal sac impaction (OR 0.53;
Table 1 Descriptive statistics for demographic characteristics in SBTs (n = 1304) and non-SBTs (n = 21,029) under primary veterinary
care in the UK
Variable Category SBT count (%) Non-SBT count (%) P-value
Age (years) ≤ 3 364 (28.2) 7776 (37.4) < 0.001
3 to < 6 332 (25.7) 5225 (25.1)
6 to < 9 288 (22.3) 3725 (17.9)
9 to < 12 195 (15.1) 2411 (11.6)
≥ 12 111 (8.6) 1639 (7.9)
Sex-neuter status Male entire 396 (30.5) 6081 (29.0) < 0.001
Male neutered 230 (17.7) 5011 (23.9)
Female entire 354 (27.3) 5330 (25.4)
Female neutered 318 (24.5) 4538 (21.7)
At/above or below mean bodyweight for breed and sex At or above 391 (30.0) 6437 (30.6) 0.264
Below 451 (34.6) 7595 (36.1)
Not recorded 462 (35.4) 6997 (33.3)
Insurance status Insured 126 (9.7) 2853 (13.6) < 0.001
Not insured 1178 (90.3) 18,176 (86.4)
Vet Group 1 10 (0.8) 67 (0.3) 0.075
2 443 (34.0) 6903 (32.8)
3 60 (4.6) 945 (4.5)
4 223 (17.1) 3592 (17.1)
5 568 (43.6) 9522 (45.3)
The P-value represents comparison of demographic variables between SBTs and non-SBTs
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95% CI 0.38 to 0.75; p < 0.001), periodontal disease (OR
0.41; 95% CI 0.32 to 0.51; p < 0.001), heart murmur (OR
0.33; 95% 0.18 to 0.60; p < 0.001), retained deciduous tooth
(OR 0.19; 95% CI 0.05 to 0.75; p = 0.018) and patellar lux-
ation (OR 0.15; 95% CI 0.04 TO 0.61; p = 0.008) (Fig. 1).
At a grouped-level of diagnostic precision, after ac-
counting for confounding using multivariable methods,
SBTs had significantly increased odds of 2/32 (6.3%)
grouped-level disorders compared to non-SBTs. These
were: mass (OR 1.51; 95% CI 1.22 to 1.88; p < 0.001) and
skin disorder (OR 1.18; 95% CI 1.00 to 1.39; p = 0.044).
Conversely, SBTs had reduced odds of 5/32 (15.6%)
grouped-level disorders compared to non-SBTs. These
were: enteropathy (OR 0.73; 95% CI 0.59 to 0.90; p =
0.004), upper respiratory tract disorder (OR 0.49; 95% CI
0.32 to 0.75; p = 0.001), anal sac disorder (OR 0.48; 95%
CI 0.35 to 0.68; p < 0.001), dental disorder (OR 0.45; 95%
CI 0.37 to 0.56; p < 0.001) and heart disease (OR 0.33;
95% CI 0.20 to 0.55; p < 0.001) (Fig. 2). The Hosmer-
Lemeshow test indicated no evidence of poor model fit
(p > 0.05) in any of these multivariable models.
Discussion
This is the largest study to date using primary-care vet-
erinary data that specifically aimed to report on SBT dis-
order predisposition and protection and used an
underlying comparator group that reflected the entire
remaining population of dogs under veterinary care. The
Fig. 1 Forest plot of the multivariable logistic regression odds ratios with corresponding 95% CIs (confidence intervals) for the combined list from
the 30 most common disorders in SBTs and in non-SBTs at a specific-level of diagnostic precision recorded in dogs under primary veterinary care
at UK practices participating in the VetCompass™ Programme from January 1st 2016 to December 31st, 2016. Model variables accounted for
included age, sex-neuter status, at/above or below mean bodyweight, insurance status and vet group. Specific-level precision describes the
original extracted terms at the maximal diagnostic precision recorded within the clinical notes
Pegram et al. Canine Medicine and Genetics            (2020) 7:13 Page 5 of 11
study characterised the demography and health of a large
cohort 22,333 dogs of which 1304 were SBTs under pri-
mary veterinary care in the UK. This has enabled report-
ing of relative predispositions to, and protections from,
disorders, as well as absolute prevalence values using
methods that have previously been restricted due to the
inability to access the large data resources required for
such analyses. This approach can now also be extended to
explore the health of many other breeds.
SBTs were no more likely to have at least one disorder
than non-SBTs (OR 0.90; p = 0.102). At a specific-level
of diagnostic precision, SBTs had higher odds of 4/36
(11.1%) disorders compared to non-SBTs and had re-
duced odds of 5/36 (13.9%) disorders. There were 27/36
(75.0%) disorders with no significant difference in odds
between SBTs and non-SBTs. At a grouped-level of
diagnostic precision, SBTs had higher odds of 2/32
(6.3%) disorders and had reduced odds of 5/32 (15.6%)
disorders compared to non-SBTs. There were 25/32
(78.1%) disorders with no significant difference in odds
between SBTs and non-SBTs. Although severity and
duration of disorder predispositions and protections
should be taken into account when fully interpreting
these results, these immediate results suggest no evi-
dence that SBTs have higher overall health problems
compared to the remainder of the general UK canine
population. Despite this overall conclusion, the current
study did identify some specific predispositions and pro-
tections that are very relevant to the breed.
The current study hypothesised that SBTs have higher
odds of aggression compared with non-SBTs. This is an
important question to answer because the perception of
differential risk of aggression between SBTs and other
breeds has a strong impact on the potential to rehome
Fig. 2 Forest plot of the multivariable logistic regression odds ratios with corresponding 95% CIs (confidence intervals) for the combined list from
the 30 most common disorders in SBTs and in non-SBTs at a grouped-level of diagnostic precision recorded in dogs under primary veterinary
care at UK practices participating in the VetCompass™ Programme from January 1st 2016 to December 31st, 2016. Model variables accounted for
included age, sex-neuter status, at/above or below mean bodyweight, insurance status and vet group. Grouped-level precision describes the
original extracted terms mapped to a general level of diagnostic precision
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SBTs [8]. However, SBTs showed no significant difference
in odds for aggression compared to non-SBTs (OR 1.09;
p = 0.644). This contrasts with previous reports that SBTs
showed higher levels of aggression compared to other dog
breeds [6, 7], although many of these reported predisposi-
tions were documented over 20 years ago. It is possible
there has since been a shift in breed behaviour, with more
SBTs kept as family pets, rather than as a status symbol as
they have been historically, reducing levels of aggression
in the breed [9]. The current study findings suggest that
potential owners visiting rehoming centres should avoid
preconceptions about the breed behaviour, as given re-
sponsible ownership and an enriched environment SBTs
can make a suitable family pet [9]. It should be noted that
all forms of aggression were grouped and evaluated as a
single disorder. The study design used for the current
study based on a spectrum of disorders managed in
primary-care practice precluded extraction of sub-
categories of aggression with deeper context. However,
future studies with specific focus on aggression could
evaluate different forms of aggression within different dog
breeds to gain a deeper understanding of these issues.
Predispositions
SBTs showed predisposition to seizure disorder at a
specific-level of diagnostic precision (OR 2.06), with
prevalence of 1.38%. SBTs were previously overrepre-
sented in a UK based study of 1260 epileptic dogs [30].
However, previous research based on primary-care data
did not identify a significantly increased or decreased
risk of epilepsy of unknown origin in SBTs compared
with crossbreeds [31]. A further report with similar
methodology identified SBTs at decreased risk (OR 0.72)
of seizure disorder compared with Labrador Retrievers
[32]. The contrasting findings in the current study may
be due to the different case definitions and comparative
populations used. The current study classified disorders
according to their most precise diagnostic term, thus
SBTs diagnosed with seizure disorder did not encompass
those dogs with a more precise term, such as epilepsy.
Therefore, the findings might suggest breed diagnostic
differences rather than a true predisposition and should
be interpreted with some caution. In addition, 18 SBTs
were recorded with seizure disorder, therefore the rela-
tively small number of cases identified may artificially in-
flate the odds ratio. SBTs have previously been reported
as predisposed to L-2HGA, an inherited metabolic dis-
order which can result in seizures [10]. None of the 18
cases mentioned L-2HGA as a cause of seizure disorder,
which may reflect the rarity of L-2HGA, however only
1/18 (5.6%) SBTs were tested based on the EPRs. There
is no known treatment for L-2HGA and seizures are
usually well controlled with anti-epileptic drugs [10].
Therefore, given that diagnosis of L-2HGA doesn’t
necessarily alter treatment outcome, it might be that
identification of this genetic mutation is a higher priority
in SBTs used for breeding to reduce risk of affected
offspring.
SBTs showed predisposition to atopic dermatitis at a
specific-level of diagnostic precision (OR 1.88). This
concurs with previous research that reported SBTs as
the breed with the fifth-highest incidence of atopic
dermatitis in insured dogs in Sweden (8.0 cases per
1000) [33]. Despite the predisposition identified, the
prevalence of atopic dermatitis in the current study was
relatively low (1.99%), compared with a US estimate of
8.7% in dogs overall [34]. Atopy is complex in its aeti-
ology and diagnosis [35, 36] and therefore the true
prevalence may be higher than reported here and thus
the disorder should be considered important for the
breed due to the associated negative impacts on quality
of life [37]. At a grouped-level of diagnostic precision,
SBTs showed predisposition to skin disorders (OR 1.18).
Whilst this would include atopic dermatitis, and possible
alternative diagnostic terms used for atopy, SBTs have
previously been identified with predisposition to
juvenile-onset demodicosis [38, 39]. Demodicosis did
not feature within the top 30 specific disorders in SBTs
or non-SBTs, however may have been included within
skin disorders at a grouped-level.
SBTs showed predisposition to skin masses at a specific-
level of diagnostic precision (OR 1.80) and masses at a
grouped-level (OR 1.51), with prevalence of 3.76 and 8.05%
respectively. A previous study based on UK primary-care
data did not find a significant difference in skin mass preva-
lence between SBTs and crossbreeds, however confounding
factors were not accounted for in this previous study and a
different comparator group was used [2]. SBTs have docu-
mented predisposition to mast cell tumours (MCTs), which
most commonly present as skin masses [40–43]. Although
predisposition to neoplasia was not identified in the current
study, it might be that a proportion of the skin masses were
MCTs, but were not investigated further and so a definitive
diagnosis not reached. SBTs have previously reported pre-
dispositions to gastric carcinoma [44], mammary carcinoma
[45], and had the eighth-highest proportional mortality
from neoplasia among pedigree breeds [17]. Therefore, it is
possible that the predisposition to masses identified in
SBTs, but not neoplasia, is reflective of diagnostic differ-
ences between breeds.
SBTs had 1.76 times the odds of stiffness at a specific-
level of diagnostic precision compared with non-SBTs,
with a prevalence of 1.15%. This finding should be inter-
preted with some caution as no significant predisposi-
tions were identified in similar categories, including
lameness, osteoarthritis and musculoskeletal disorders.
Stiffness is a clinical sign commonly associated with
musculoskeletal disorders, but is not a formal biomedical
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diagnosis in itself [46]. Therefore, the predisposition to
stiffness reported may be a reflection of the different
language or diagnostic criteria used by veterinarians be-
tween different dog breeds. It may also indicate that
musculoskeletal disorders in SBTs appear relatively mild,
therefore “stiffness” may not be categorised at a further
diagnostic level. Indeed, veterinarians rated Pitbull breed
types with low pain sensitivity compared with other
breeds and gave lower ratings for Pitbull breed types
than the general public [47]. Given the prevalence of
elbow dysplasia in SBTs previously reported as 31.3–
33.3% [48, 49] and the documented stoicism of the breed
[50], it might be that “stiffness” is indicative of an under-
lying condition that may warrant further investigation.
The UK KC offers eye testing and DNA tests for HC-
HSF4 and L-2HGA in SBTs, inherited conditions to
which the breed is reportedly predisposed [1]. These
conditions were not identified in sufficient numbers to
be included in the current study. This may reflect a true
rarity of these disorders, or it could be that they are just
not routinely tested for. Further studies evaluating the
prevalence of these disorders would be useful to deter-
mine the value of genetic testing in the breed.
Protections
SBTs showed protection to patella luxation at a specific-
level of diagnostic precision (OR 0.15), with prevalence of
0.15%. This is in agreement with previous research based
on primary-care data in which SBTs had 0.5 times the
odds of patella luxation compared with crossbreeds [51].
As a protected breed, SBTs could be used as a model to
explore conformational and other factors that may assist
to develop strategies to reduce the prevalence in other
higher-risk breeds, such as the Bichon and Bulldog.
SBTs showed protection to enteropathy (OR 0.78,
prevalence 7.29%) and anal sac disorder (OR 0.48, preva-
lence 2.84%) at a grouped-level of diagnostic precision
and anal sac impaction at a specific-level (OR 0.53,
prevalence 2.61%). This is similar to previous research
based on primary-care data in which prevalence of en-
teropathy and anal sac disorder were lower for SBTs
compared with crossbreeds [2]. Although enteropathy is
a broad term, soft faeces and inflammatory bowel dis-
ease have been associated with anal sac disease [52],
therefore enteropathy and anal sac disorders are some-
what interlinked and may share some of the same risk
factors, including diet [52, 53]. It might also be that re-
duced risk of anal sac disorders is linked to conform-
ation, with SBTs being a highly muscular breed [1].
Further research exploring the mechanisms underlying
these protective effects in SBTs may benefit the at-risk
breeds in the population.
SBTs showed protection to dental disorders at a
grouped-level of diagnostic precision (OR 0.45) and
periodontal disease (OR 0.41) and retained deciduous
tooth (OR 0.19) at a specific-level. This is in agreement
with previous research based on a primary-care popula-
tion in which SBTs had a lower prevalence of dental dis-
order compared to crossbreeds (3.0% versus 9.8%) [2].
Although SBTs had protection to dental disorders in the
current study, they still had a relatively high prevalence of
such conditions (7.82% for dental disorders and 6.52% for
periodontal disease). Exploration of the reasons why SBTs
are protected in comparison to other breeds may enable
these protective factors to be increased so that the breed
prevalence decreases further, and equally that the health
and welfare of other breeds might also be improved.
SBTs showed protection to heart disease at a grouped-
level of diagnostic precision (OR 0.33) and heart murmurs
at a specific-level (OR 0.33), with prevalence of 1.15 and
0.84% respectively. This is in agreement with previous re-
search in which prevalence of heart disease and heart mur-
mur were lower for SBTs than for crossbreeds under
primary-care in the UK [2]. In addition, SBTs have previ-
ously been reported at lower odds (OR 0.25) of degenera-
tive mitral valve disease compared with crossbreeds [54]. It
might be that the historic use of SBTs as a fighting dog and
“muscular, active and agile” appearance [1] has resulted in
residual protection to cardiac disorders even in today’s
dogs. Therefore, this could suggest some value in using
SBTs in cross breeding programmes to outcross other
breeds affected with specific cardiac predispositions [55].
SBTs showed protection to upper respiratory tract disorder
at a grouped-level of diagnostic precision (OR 0.49), with
prevalence of 1.69%. To the authors’ knowledge this protec-
tion has not been documented previously, therefore future
work may explore this novel finding in greater detail. SBTs
have been reported as at-risk to Brachycephalic Obstructive
Airway Syndrome (BOAS) [56, 57], which can be charac-
terised by increased and/or abnormal upper respiratory tract
noise [58]. BOAS was not one of the most common disor-
ders recorded in SBTs or non-SBTs in the current study,
however is thought to be underreported in veterinary clinic
records due to psychological desensitisation via normalisa-
tion in commonly affected breeds [59]. SBTs have been doc-
umented as having “noisy breathing” [60], however it may be
that this is “accepted” by owners and veterinary professionals
as a typical breed characteristic rather than the possibility of
associated underlying pathology. Given the popularity of bra-
chycephalic (“flat-faced”) dogs, but their intrinsic health and
welfare issues [61], breeding away from this phenotype in
SBTs should be encouraged.
Limitations
The limitations of this study include those reported in
previous VetCompass publications based on similar
methods that applied retrospective analysis of primary-
care EPR data [2, 62]. Additionally, the current study did
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not account for differences in severity and duration be-
tween disorders, which could provide further insights
into the nature and ranking of breed predispositions
[63]. Comparing the relative number of predispositions
to protections does not necessarily reflect breed health
without a measure of severity, however the study find-
ings highlight the types of conditions SBTs are predis-
posed to and protected from.
A number of the predispositions identified, including
seizure disorder, skin mass, stiffness and mass and the
protections, including heart murmur, were the residual
groupings when a more precise diagnosis was not reached.
Therefore, these findings need to be interpreted with
some caution, as they may reflect diagnostic differences
between SBTs and other dog breeds rather than a true
predisposition or protection. The greatest confidence may
be given to predispositions identified at the greatest level
of diagnostic precision, namely atopic dermatitis.
Although dogs were classified using a dualist system as ei-
ther ‘SBT’ or ‘non-SBT’, the high proportion (26.8%) of
crossbreeds among the non-SBTs might have caused some
dilution of the phenotype given that some of these cross-
breds may have included some SBT parentage. In addition,
SBTs can be difficult to identify based on appearance alone,
with some disagreement in classification of SBTs and Pit
Bulls (based on photographs) reported between UK and US
shelter workers [64]. However, difficulty in breed classifica-
tion is not necessarily confined to one specific breed type,
therefore it is unlikely misclassification was unidirectional.
This study used multiple comparisons. Strict adherence to
a cut-off P-value of 0.05 to infer significance for multiple
comparisons can lead to a Type 1 error of accepting false
positive results. Furthermore, the small number of cases in
some disorders reported might have led to a type 2 error of
accepting false negative results [65]. We recommend that
readers do not rely on the P-values of odds ratios alone, but
consider the confidence intervals and prevalence percentages
when interpreting the current results [66]. Consequently, the
individual results for each of the disorders assessed should
be interpreted as exploratory rather than confirmatory.
Conclusion
This study evaluated a range of disorders and should be
considered exploratory rather than confirmatory. The in-
dividual results should be confirmed in future a priori
studies to increase confidence in the findings. From the
relative number of predispositions to protections identi-
fied, there is no evidence that SBTs have higher overall
health problems than non-SBTs. The study hypothesized
that SBTs would have higher odds of aggression than
non-SBTs, however no significant difference in odds was
identified. The type of disorder predispositions and pro-
tections reported suggest diagnostic differences between
dog breeds, which further work might help elucidate.
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